Journal profile · Medicine-Immunology and Allergy
Immunity Inflammation and Disease
ISSN 2050-4527 · Wiley-Blackwell · ENGLAND
Immunity Inflammation and Disease: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.52; fully open access; APC about USD 3,400; median 247 days to acceptance (102 articles, last 24 months); acceptance rate 24% (journal website); 224 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunity Inflammation and Disease is published by Wiley-Blackwell and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, Asthma and respiratory diseases and SARS-CoV-2 and COVID-19 Research, together about 22.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Immunity, Inflammation and Disease is a peer-reviewed immunology journal, publishing clinical and basic research in immunology and allied fields.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Immunology and Allergy
Editor-in-chief Alexander HutchisonPublisher website
Editorial board by country: 5 in mainland China (about 17%); most named United States 10, Mainland China 5, India 5, United Kingdom 1, South Korea 1 (29 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine8.5%
- Asthma and respiratory diseasesMedicine8%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.5%
- Immune Response and InflammationImmunology and Microbiology5.6%
- Immune cells in cancerImmunology and Microbiology5%
- Allergic Rhinitis and SensitizationMedicine4.3%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology4.2%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.52LetPub ·
- Impact factor (publisher)
- 3.5Publisher website ·
- Impact factor (publisher) 2025
- 3.5Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- CiteScore (publisher)
- 5.4Publisher website ·
- CiteScore (publisher) 2025
- 5.4Publisher website ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 52OpenAlex ·
- i10-index
- 680OpenAlex ·
- 2-year mean citedness
- 4.15OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 179LetPub ·
- Articles per year (publisher) 2025
- 180Publisher website ·
- Downloads per year (publisher) 2025
- 697,692Publisher website ·
Articles by year OpenAlex count · 1,952 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 220 | 220 | 86 |
| 2025 | 224 | 224 | 677 |
| 2024 | 369 | 369 | 2,607 |
| 2023 | 362 | 362 | 3,996 |
| 2022 | 176 | 176 | 1,898 |
| 2021 | 190 | 190 | 3,710 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
247 daysMedian, submission to acceptance · P25–P75 150 days – 348 days
- Acceptance to online
- median 19 days (102 articles)
- Submission to online
- median 274 days
- Sample
- 102 articles with submission and acceptance dates (502 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Acceptance rate (publisher)
- 24%Publisher website ·
- Acceptance rate (publisher) 2025
- 24%Publisher website ·
- Submission to first decision
- 15 daysPublisher website ·
- Submission to first decision 2025
- 15 daysPublisher website ·
- Submission to acceptance 2025
- 234 daysPublisher website ·
- Acceptance to publication 2025
- 20 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,400 / GBP 2,100 / EUR 2,810 | Yes | CC BY | |
| OpenAlex | USD 3,300 / EUR 2,480 / GBP 2,100 | — | — | |
| LetPub | USD 3,060 / GBP 1,960 / EUR 2,320 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
Article types accepted12, with length limits
- commentaryArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- letter to the editorArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- letters to the editorArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…main text ≤ 1,500 words
- meta-analysisArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- opinionArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- original articleArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- registered reportArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- registered reports (stage 1 and 2)Registered Reports (Stage 1 and 2) See the Registered Reports Author Guidelines for full details.Length not stated
- reviewArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- review articleArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
- short reportsShort Reports Abstract should be 150 words maximum, 2,000 words maximum in the main document and 4 figures/tables and 15 references maximum.Length not stated
- systematic reviewArticle Type Description Original Article Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Review Arti…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use AI Policy
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…
Source ↗Publisher website ·- Authorship Authorship
ORCID requirement Model summary
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Publication ethics
COPE core practices Model summary
This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices).
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
Creative Commons license Model summary
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.
Source ↗Publisher website ·- Open access Open Access
Preprint policy: Please find the Wiley preprint policy here. This journal accepts articles previously published on preprint servers. Immunity, Inflammation and Disease will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article i…
Source ↗Publisher website ·- Peer review 1. Submission and Peer Review Process
Single-blind peer review Model summary
Submission Once the submission materials have been prepared in accordance with the author guidelines, new submissions should be made via the Research Exchange submission portal: https://wiley.atyponrex.com/journal/IID3. You may check the status of your submission at any time by logging on to submission.wiley.com and clicking the "My Submissions" button. For technical help with the submission syste…
Source ↗Publisher website ·- Plagiarism
iThenticate CrossCheck Model summary
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints
Preprint policy Model summary
This journal accepts articles previously published on preprint servers.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2050-4527
- Latest issue on the website
- Volume 14, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Immunity Inflammation and Disease
What CAS zone is Immunity Inflammation and Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunity Inflammation and Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunity Inflammation and Disease?
The latest impact factor listed by LetPub is 3.52; CiteScore 5.4, h-index 52.
How long does peer review take at Immunity Inflammation and Disease?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 247 days (interquartile range 150–348 days); authors report an average review time of about 8 weeks; the journal's website gives an acceptance rate of 24% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Immunity Inflammation and Disease?
According to the journal's author guidelines: Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Immunity Inflammation and Disease based?
Of the 29 board members whose country the journal's board page names, 5 (about 17%) are in mainland China; the countries named most often are United States (10), Mainland China (5) and India (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunity Inflammation and Disease?
According to LetPub and DOAJ records, Immunity Inflammation and Disease is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science and MEDLINE; that list has not been checked against each database.
Is Immunity Inflammation and Disease open access, and what is the APC?
Immunity Inflammation and Disease is a fully open-access journal. APC about USD 3,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .